Lunan Pharmaceutical

Lunan Pharmaceutical Group is a comprehensive pharmaceutical group that integrates the production, research, and sales of traditional Chinese medicine, chemical medicines, and biologics. It is a national innovative enterprise and a key high-tech enterprise under the National Torch Program. Its member companies include Lunan Houpu Pharmaceutical Co., Ltd., Lunan Better Pharmaceutical Co., Ltd., Shandong New Era Pharmaceutical Co., Ltd., and Lunan New Era Medicine Co., Ltd. The group ranks among the top 500 in competitiveness among large enterprise groups in China, the top 500 private enterprises in manufacturing in China, and has been listed on the top 100 tax-paying enterprises in Shandong Province for many consecutive years. In 2019, it ranked 22nd on the list of China's top 100 pharmaceutical industrial enterprises, and in 2021, the brand value of Lunan Pharmaceutical reached 12.191 billion yuan.The group has established several high-level research and development platforms, including the National Engineering Research Center for Chiral Pharmaceuticals, the National Engineering Laboratory for High-Efficiency Expression in Mammalian Cells, the State Key Laboratory of Generic Technology for Traditional Chinese Medicine Manufacturing, and a national-level enterprise technology center. It has established technical cooperation with more than 100 universities and research institutes at home and abroad. The innovation capability of the enterprise technology center ranks among the forefront of the pharmaceutical industry in China, and it was listed among the top 100 in the 2017 ranking of Chinese enterprise innovation capabilities. It has won one second prize of the National Technology Invention Award and seven second prizes of the National Science and Technology Progress Award, and in 2018, it received the "Ho Leung Ho Lee Foundation Science and Technological Innovation Award." The company has established a quality assurance system aligned with international quality supervision concepts such as ICH, FDA, and EDQM. All dosage forms and varieties have passed the new version of China's GMP certification and have been awarded the title of "Best Industrial Enterprise in China's Pharmaceutical R&D Product Line" multiple times. The overall quality management level ranks among the top in the same industry nationwide. The company leads the industry in product quality, independent innovation capability, and management level, and is listed among the top 500 in China's enterprise patents, winning the sixth Shandong Provincial Governor's Quality Award.